These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34890043)

  • 21. Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease.
    Oh S; Tanaka K; Tsujimoto T; So R; Shida T; Shoda J
    Metab Syndr Relat Disord; 2014 Jun; 12(5):290-8. PubMed ID: 24689911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follicle-stimulating hormone is associated with non-alcoholic fatty liver disease in Chinese women over 55 years old.
    Wang N; Li Q; Han B; Chen Y; Zhu C; Chen Y; Xia F; Lu M; Meng Y; Guo Y; Ye L; Sui C; Kuang L; Lin D; Lu Y
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1196-202. PubMed ID: 26678239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Royal jelly attenuates nonalcoholic fatty liver disease by inhibiting oxidative stress and regulating the expression of circadian genes in ovariectomized rats.
    You MM; Liu YC; Chen YF; Pan YM; Miao ZN; Shi YZ; Si JJ; Chen ML; Hu FL
    J Food Biochem; 2020 Mar; 44(3):e13138. PubMed ID: 31894585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.
    Klair JS; Yang JD; Abdelmalek MF; Guy CD; Gill RM; Yates K; Unalp-Arida A; Lavine JE; Clark JM; Diehl AM; Suzuki A;
    Hepatology; 2016 Jul; 64(1):85-91. PubMed ID: 26919573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic fatty liver disease and polycystic ovary syndrome.
    Vassilatou E
    World J Gastroenterol; 2014 Jul; 20(26):8351-63. PubMed ID: 25024594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic fatty liver disease and metabolic syndrome in postmenopausal women.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Santos ME; Nahas EA
    Gynecol Endocrinol; 2014 May; 30(5):325-9. PubMed ID: 24460502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Independent and Synergistic Associations of Aerobic Physical Activity and Resistance Exercise with Nonalcoholic Fatty Liver Disease.
    Yang HJ; Hong YP; Yoon TY; Ryoo JH; Choi JM; Oh CM
    Gut Liver; 2023 Jul; 17(4):600-609. PubMed ID: 36928126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Sandrim VC; Muniz LG; Nahas EA
    Metab Syndr Relat Disord; 2014 Aug; 12(6):330-8. PubMed ID: 25051240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women.
    Kim MK; Ahn CW; Nam JS; Kang S; Park JS; Kim KR
    Menopause; 2015 Dec; 22(12):1323-7. PubMed ID: 26154274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease.
    Kwak MS; Kim D; Chung GE; Kim W; Kim JS
    Liver Int; 2017 Jun; 37(6):919-926. PubMed ID: 27917585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of anthropometric indices for the screening of nonalcoholic fatty liver disease in pre- and postmenopausal women.
    Hong SH; Hwang SY; Kim JA; Lee YB; Roh E; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
    Menopause; 2020 Jan; 27(1):88-94. PubMed ID: 31613826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationship between normal serum uric acid levels and nonalcoholic fatty liver disease in postmenopausal women].
    Liu P; Ma F; Lou H; Zhu Y; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):53-7. PubMed ID: 24721245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation.
    Farzanegi P; Dana A; Ebrahimpoor Z; Asadi M; Azarbayjani MA
    Eur J Sport Sci; 2019 Aug; 19(7):994-1003. PubMed ID: 30732555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review.
    Mascaró CM; Bouzas C; Tur JA
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of serum ferritin levels with non-alcoholic fatty liver disease in postmenopausal women.
    Kim HB; Lee HS; Lee YJ
    Climacteric; 2018 Oct; 21(5):509-514. PubMed ID: 30106314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between nonalcoholic fatty liver disease and bone mineral density in postmenopausal women.
    Lee DY; Park JK; Hur KY; Um SH
    Climacteric; 2018 Oct; 21(5):498-501. PubMed ID: 30122075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding nutritional interventions and physical exercise in non-alcoholic fatty liver disease.
    Ordonez R; Carbajo-Pescador S; Mauriz JL; Gonzalez-Gallego J
    Curr Mol Med; 2015; 15(1):3-26. PubMed ID: 25601465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between nonalcoholic fatty liver and increased low-level albuminuria in postmenopausal women in China: A cross-sectional study.
    Su W; Wang Y; Chen K; Wang J; Wang A; Tang X; Yan L; Luo Z; Qin G; Chen L; Ning G; Mu Y
    J Diabetes; 2021 Jun; 13(6):494-505. PubMed ID: 33200507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effect of Menopausal Status, Insulin Resistance and Body Mass Index on the Prevalence of Non-Alcoholic Fatty Liver Disease.
    Ntikoudi A; Spyrou A; Evangelou E; Dokoutsidou E; Mastorakos G
    Healthcare (Basel); 2024 May; 12(11):. PubMed ID: 38891156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menopause Does Not Affect Fatty Liver Severity In Women: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Osella AR; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Chiloiro M; Leandro G; Correale M; Tutino V; Misciagna G; Bonfiglio C; Caruso MG
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):513-521. PubMed ID: 29692271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.